Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Amarin Corp Plc
(NQ:
AMRN
)
6.600
USD
-0.020 (-0.30%)
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 18, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Amarin Corp Plc
< Previous
1
2
3
4
5
6
7
8
9
...
39
40
Next >
Investors Alert: Amarin Corporation plc, Xilinx, Schlumberger Limited, Cypress Semiconductor Corporation
April 18, 2013
Lakeway, NY -- (SBWIRE) -- 04/18/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on...
Read More
from
SBWire - Latest Press Releases
Amarin (AMRN) Approved to Add Chemport as Additional Vascepa API Supplier
April 18, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8261350 for the full story.
Read More
from
StreetInsider.com News Articles
Amarin Announces Approval of Supplemental New Drug Application for Chemport as Additional Vascepa(R) Active Pharmaceutical Ingredient Supplier
April 18, 2013
from
GlobeNewswire News Releases
Amarin Shares Down 27.5% Since SmarTrend's Sell Call (AMRN)
April 17, 2013
from
Comtex SmarTrend® News Briefs
8 Biotechnology Stocks to Sell Now
April 17, 2013
Read More
category
NASDAQ:TSRX
,
NASDAQ:ACHN
,
NASDAQ:EXEL
, and 6 more.
from
InvestorPlace - Latest Headlines
Stock Losers: MBIA Inc, Graphic Packaging Holding Company, Amarin Corporation plc, DiamondRock Hospitality Company
April 16, 2013
Dallas, TX -- (SBWIRE) -- 04/16/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the...
Read More
from
SBWire - Latest Press Releases
Amarin, Pharmacyclics, Anthera Pharma, Star Scientific, and Impax Laboratories Under StockCall's Microscope
April 16, 2013
from
PR Newswire
NASDAQ Decliners Watch List: Amarin Corporation plc (NASDAQ:AMRN) and Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Added to Equity Profile Report's NASDAQ Decliners Watch List.
April 15, 2013
Wilmington, DE -- (SBWIRE) -- 04/15/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Amarin Corporation plc (NASDAQ:AMRN) and Sarepta Therapeutics, Inc....
Read More
from
SBWire - Latest Press Releases
No NCE for Amarin’s Vascepa, Launch Trudges Along
April 15, 2013
It was another month, and another non-decision on the NCE status of Amarin Corporation’s (NASDAQ: AMRN)Vascepa (icosapent ethyl), which is an unsurprising but significant short-term blow to investor...
Read More
category
AMRN
,
Brian L/ Wilson
from
Bio-Wire.Com
Abbott: Galectin-3 Assay Sees Approval & Builds Takeover Case for La Jolla Pharmaceuticals
April 15, 2013
Galectin-3: Brief Overview Galectins are a very interesting family of proteins that are part of the bigger class of proteins known as “lectins”. Lectins are proteins that interact with carbohydrate...
Read More
category
LJPC
,
Brian L/ Wilson
,
ABT
from
Bio-Wire.Com
Stock Losers: Molycorp Inc, ISIS Pharmaceuticals, Amarin Corporation plc, Panasonic Corporation
April 12, 2013
Dallas, TX -- (SBWIRE) -- 04/12/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the...
Read More
from
SBWire - Latest Press Releases
Amarin (AMRN) Vascepa Exclusivity Status Not in FDA Orange Book March Update
April 12, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8250044 for the full story.
Read More
from
StreetInsider.com News Articles
BioStock Break Out Watch List Initiated with ACAD, AMRN and CELG
April 11, 2013
from
ACCESSWIRE
7 Biotechnology Stocks to Sell Now
April 10, 2013
Read More
category
NASDAQ:TSRX
,
NASDAQ:ACHN
,
NASDAQ:EXEL
, and 5 more.
from
InvestorPlace - Latest Headlines
Amarin Down 24.4% Since SmarTrend Downtrend Call (AMRN)
April 09, 2013
from
Comtex SmarTrend® News Briefs
US Stocks Alert: The Boeing Company, the Home Depot, Amarin Corporation Plc, Banco Bradesco SA
April 09, 2013
Lakeway, TX -- (SBWIRE) -- 04/09/2013 -- vbtrendreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the...
Read More
from
SBWire - Latest Press Releases
Streetinsider.com's Hot Lunchtime Reads 04/08: (HPQ) (AMRN) (JPM) (QCOR)
April 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8238806 for the full story.
Read More
from
StreetInsider.com News Articles
Bio-Wire Weekly (4/1/13 – 4/5/13)
April 08, 2013
Bio-Wire Weekly (4/1/13 – 4/5/13) Want to get this earlier? Just sign up for our mailing list for free The Newsmakers: Amarin Corporation (NASDAQ: AMRN) It seems that the heat between the bull/bear...
Read More
category
Uncategorized
from
Bio-Wire.Com
Amarin (AMRN) Vascepa Added to CVS (CVS) Health Plan
April 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8238705 for the full story.
Read More
from
StreetInsider.com News Articles
NASDAQ Gainers Watch List: BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) and Amarin Corporation Plc (NASDAQ:AMRN) Added to Growing Stock Report's NASDAQ Gainers Watch List.
April 08, 2013
New York, NY -- (SBWIRE) -- 04/08/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) and Amarin Corporation plc...
Read More
from
SBWire - Latest Press Releases
Amarin (AMRN) Issues Encouraging Update on Vascepa MARINE, ANCHOR Phase 3s
April 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8237358 for the full story.
Read More
from
StreetInsider.com News Articles
Amarin Announces New Clinical Data Showing Significant Reductions in Apolipoprotein C-III Levels in MARINE and ANCHOR Studies of Vascepa(R)
April 08, 2013
from
GlobeNewswire News Releases
NASDAQ Decliners Watch List: Zogenix, Inc. (NASDAQ:ZGNX) and Amarin Corporation plc (NASDAQ:AMRN) Added to Equity Profile Report's NASDAQ Decliners Watch List.
April 06, 2013
New York, NY -- (SBWIRE) -- 04/06/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Zogenix, Inc. (NASDAQ:ZGNX) and Amarin Corporation plc (NASDAQ:AMRN).
Read More
from
SBWire - Latest Press Releases
7 Biotechnology Stocks to Sell Now
April 03, 2013
Read More
category
NASDAQ:TSRX
,
NASDAQ:ACHN
,
NASDAQ:EXEL
, and 5 more.
from
InvestorPlace - Latest Headlines
Downtrend Call Working As Amarin Stock Falls 21.9% (AMRN)
April 02, 2013
from
Comtex SmarTrend® News Briefs
Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR), Mellanox Technologies, Ltd. (NASDAQ:MLNX), and Amarin Corporation Plc (NASDAQ:AMRN) Added to Growing Stock Report's NASDAQ Gainers Watch List.
April 02, 2013
New York, NY -- (SBWIRE) -- 04/02/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR), Mellanox Technologies, Ltd....
Read More
from
SBWire - Latest Press Releases
Amarin's (AMRN) Vascepa Has a Strong Week of Prescription Growth, But Is It Enough?
April 02, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8225121 for the full story.
Read More
from
StreetInsider.com News Articles
NASDAQ Gainers Watch List: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) and Amarin Corporation Plc (NASDAQ:AMRN) Added to Growing Stock Report's NASDAQ Gainers Wa
April 01, 2013
New York, NY -- (SBWIRE) -- 04/01/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) and...
Read More
from
SBWire - Latest Press Releases
Leerink Analyst Says Prescriptions for Amarin's Vascepa 'Tracking Well'
April 01, 2013
Leerink Swann's Joseph Schwartz issued a note earlier Monday suggesting prescriptions for Amarin's (NASDAQ: AMRN ) Vascepa are "tracking well." The analyst said recent IMS data showed Vascepa...
Read More
category
Benzinga
,
AMRN
,
Analyst Ratings
, and 1 more.
from
Latest Articles from Benzinga.com
Streetinsider.com's Hot Lunchtime Reads 04/01: (JCP) (AMRN) (AAPL) (BBBY) (CSCO)
April 01, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8221524 for the full story.
Read More
from
StreetInsider.com News Articles
< Previous
1
2
3
4
5
6
7
8
9
...
39
40
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here